Market Overview:
The global drug-coated balloons (DCBs) market is expected to grow at a CAGR of 10.8% from 2018 to 2030, according to a new study by MarketsandMarkets. The growth of the market can be attributed to the increasing incidence of peripheral artery diseases (PAD), technological advancements in DCB products, and rising demand for minimally invasive procedures. Based on type, the DCB for PAD segment is expected to account for the largest share of the global DCB market in 2018. This segment is also projected to grow at a higher CAGR than other segments during the forecast period. The large share and high growth rate of this segment are mainly due to increasing incidence rates of PAD across the globe and technological advancements in DCB products specifically designed for treating PAD patients. Based on application, hospitals are expected to account for the largest share ofthe global DCB market in 2018.
Product Definition:
A drug-coated balloon (DCB) is a medical device that is used during angioplasty procedures to open blocked coronary arteries. A DCB is a type of percutaneous transluminal coronary angioplasty (PTCA) device. It consists of a thin, wire mesh tube called a catheter that is inserted into the artery through a small incision in the groin. The catheter is then threaded up to the heart where it inflates two small balloons at its tip. The balloons are then used to push aside any blockages and open up the artery so that blood can flow freely again.
DCB for Peripheral Artery Disease:
DCB for PAD is a biocompatible, hydrogel-based implant that serves as an alternative to the native peripheral artery. The primary function of DCB in PAD treatment is to support and maintain the integrity of blood vessels. It does this by physically blocking or slowing down the migration of platelets and other inflammatory cells from the site of damage in arteries.
DCB for Coronary Artery Disease:
DCB for Coronary Artery Disease is a medical device used to treat coronary artery disease. It consists of two balloon catheters, one male and the other female, which are connected by an L-shaped plastic tube. The male end of the tube is inserted into the patient’s artery while the female end is placed in a blood vessel near the heart.
Application Insights:
Based on application, the global market is segmented into hospitals, cardiac catheterization labs, and other centers. Hospitals held the largest share of over 70.0% in 2017 owing to growing usage of these devices for treating life-threatening conditions such as heart attack and stroke. In addition, increasing hospital admissions due to Cardiac arrest also boosts product demand in this segment.
The use of drug-coated balloons for coronary artery disease has been proven effective than conventional treatment methods such as surgery or medication alone in controlling angina pectoris caused by insufficient blood flow to the heart muscles during exercise or rest. This factor is anticipated to boost their usage over the forecast period driving growth of this market at a CAGR exceeding 7%.
In addition, these devices help reduce mortality rates associated with Coronary Artery Disease (CAD) by 50% when compared with conventional treatments which further propels its demand worldwide driven majorly by countries such as Germany.
Regional Analysis:
North America dominated the global market in 2017. The growth can be attributed to an increase in the prevalence of chronic conditions, such as peripheral artery disease and coronary artery disease, which mandates frequent hospital visits and cardiac catheterization procedures. Moreover, increasing government initiatives for R&D activities pertaining to advanced medical treatments are expected to fuel regional demand over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and growing patient awareness regarding available treatment options. Furthermore, a rise in majorly cardiovascular diseases due to unhealthy lifestyles will drive regional product demand during the forecast period.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs) is expected to drive the demand for drug-coated balloons over the forecast period.
- Rising geriatric population is also anticipated to fuel the growth of this market as they are more susceptible to CVDs.
- Technological advancements in drug-coated balloons are likely to propel their uptake in the coming years.
- Growing preference for minimally invasive procedures over traditional open heart surgeries is projected to boost demand for these devices globally.
- rising healthcare expenditure and growing awareness about benefits associated with drug-coated balloons are estimated to create lucrative opportunities for market players in this domain during the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug-Coated Balloons Market Research Report
By Type
DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease, DCB for Other Indications
By Application
Hospitals, Cardiac Catheterization Labs, ASCs
By Companies
Medtronic, BD, B. Braun Melsungen, Koninklijke Philips, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, BioMed, Concept Medical, Cardionovum, Endocor, Hexacath Sverige, iVascular SLU, Minvasys, MedAlliance, QT Vascular, RD Global-Invamed, SurModics, Terumo, Wellinq
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Drug-Coated Balloons Market Report Segments:
The global Drug-Coated Balloons market is segmented on the basis of:
Types
DCB for Peripheral Artery Disease, DCB for Coronary Artery Disease, DCB for Other Indications
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Cardiac Catheterization Labs, ASCs
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- BD
- B. Braun Melsungen
- Koninklijke Philips
- Boston Scientific
- Opto Circuits (India)
- Acotec Scientific
- AR Baltic Medical
- Acrostak
- Biosensors International Group
- BioMed
- Concept Medical
- Cardionovum
- Endocor
- Hexacath Sverige
- iVascular SLU
- Minvasys
- MedAlliance
- QT Vascular
- RD Global-Invamed
- SurModics
- Terumo
- Wellinq
Highlights of The Drug-Coated Balloons Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DCB for Peripheral Artery Disease
- DCB for Coronary Artery Disease
- DCB for Other Indications
- By Application:
- Hospitals
- Cardiac Catheterization Labs
- ASCs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug-Coated Balloons Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug-coated balloons are a type of balloon that is coated with a medication to help relieve pain. The balloon is inserted into the patient's mouth and inflated, which causes the medication to be released and absorbed by the patient's body.
Some of the major players in the drug-coated balloons market are Medtronic, BD, B. Braun Melsungen, Koninklijke Philips, Boston Scientific, Opto Circuits (India), Acotec Scientific, AR Baltic Medical, Acrostak, Biosensors International Group, BioMed, Concept Medical, Cardionovum, Endocor, Hexacath Sverige, iVascular SLU, Minvasys, MedAlliance, QT Vascular, RD Global-Invamed, SurModics, Terumo, Wellinq.
The drug-coated balloons market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug-Coated Balloons Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug-Coated Balloons Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug-Coated Balloons Market - Supply Chain
4.5. Global Drug-Coated Balloons Market Forecast
4.5.1. Drug-Coated Balloons Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug-Coated Balloons Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug-Coated Balloons Market Absolute $ Opportunity
5. Global Drug-Coated Balloons Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug-Coated Balloons Market Size and Volume Forecast by Type
5.3.1. DCB for Peripheral Artery Disease
5.3.2. DCB for Coronary Artery Disease
5.3.3. DCB for Other Indications
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug-Coated Balloons Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug-Coated Balloons Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Cardiac Catheterization Labs
6.3.3. ASCs
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug-Coated Balloons Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug-Coated Balloons Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug-Coated Balloons Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug-Coated Balloons Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug-Coated Balloons Demand Share Forecast, 2019-2026
9. North America Drug-Coated Balloons Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug-Coated Balloons Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug-Coated Balloons Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Cardiac Catheterization Labs
9.4.3. ASCs
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug-Coated Balloons Market Size and Volume Forecast by Type
9.7.1. DCB for Peripheral Artery Disease
9.7.2. DCB for Coronary Artery Disease
9.7.3. DCB for Other Indications
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug-Coated Balloons Demand Share Forecast, 2019-2026
10. Latin America Drug-Coated Balloons Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug-Coated Balloons Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug-Coated Balloons Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Cardiac Catheterization Labs
10.4.3. ASCs
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug-Coated Balloons Market Size and Volume Forecast by Type
10.7.1. DCB for Peripheral Artery Disease
10.7.2. DCB for Coronary Artery Disease
10.7.3. DCB for Other Indications
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug-Coated Balloons Demand Share Forecast, 2019-2026
11. Europe Drug-Coated Balloons Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug-Coated Balloons Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug-Coated Balloons Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Cardiac Catheterization Labs
11.4.3. ASCs
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug-Coated Balloons Market Size and Volume Forecast by Type
11.7.1. DCB for Peripheral Artery Disease
11.7.2. DCB for Coronary Artery Disease
11.7.3. DCB for Other Indications
11.8. Basis Point Share (BPS) Analysis by Typ
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug-Coated Balloons Demand Share, 2019-2026
12. Asia Pacific Drug-Coated Balloons Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug-Coated Balloons Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug-Coated Balloons Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Cardiac Catheterization Labs
12.4.3. ASCs
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug-Coated Balloons Market Size and Volume Forecast by Type
12.7.1. DCB for Peripheral Artery Disease
12.7.2. DCB for Coronary Artery Disease
12.7.3. DCB for Other Indications
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug-Coated Balloons Demand Share, 2019-2026
13. Middle East & Africa Drug-Coated Balloons Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug-Coated Balloons Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug-Coated Balloons Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Cardiac Catheterization Labs
13.4.3. ASCs
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug-Coated Balloons Market Size and Volume Forecast by Type
13.7.1. DCB for Peripheral Artery Disease
13.7.2. DCB for Coronary Artery Disease
13.7.3. DCB for Other Indications
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug-Coated Balloons Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug-Coated Balloons Market: Market Share Analysis
14.2. Drug-Coated Balloons Distributors and Customers
14.3. Drug-Coated Balloons Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BD
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. B. Braun Melsungen
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Koninklijke Philips
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Boston Scientific
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Opto Circuits (India)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Acotec Scientific
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. AR Baltic Medical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Acrostak
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Biosensors International Group
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. BioMed
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Concept Medical
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Cardionovum
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Endocor
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Hexacath Sverige
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. iVascular SLU
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Minvasys
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. MedAlliance
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. QT Vascular
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. RD Global-Invamed
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
